Navigation Links
BCC Research Publishes a New Report on Separation Systems for Commercial Biotechnology Markets

Wellesley, MA (PRWEB) September 15, 2013

According to a new technical market research report, Separation Systems for Commercial Biotechnology from BCC Research (, the global market for commercial biotechnology separation systems was valued at $16 billion in 2012 and is expected to reach $17.1 billion in 2013. BCC Research projects the market to reach nearly $27.8 billion by 2018, and register a compound annual growth rate (CAGR) of 10.1%.

As an application of commercial biotechnology, protein separation systems are playing an increasingly important role in new biopharmaceutical development. Protein separation systems do not require U.S. Food and Drug Administration (FDA) approval, but the products produced from these processes do, and they must be produced in accordance with FDA good manufacturing practices (GMP) guidelines. Thus, separation processes and equipment such as protein microarrays, lab-on-a-chip, biochips, DNA microarrays, flow cytometry and magnetic separation must pass FDA audits of the manufacturing process.

The biomolecule separation market is positioned for significant growth in the next five years. This is due to new protein and other biomolecule products that will require separation technology, as well as new innovations in the technology itself. The development of proteins as biotherapeutic agents against a number of human diseases by the biomedical and pharmaceutical industry is helping the industry achieve a higher growth rate. The recognition of this technology in emerging markets such as Japan and the Pacific Rim countries is also expected to contribute to further growth. In addition, continued global growth is expected to accrue as a result of the growing middle class in countries such as India, China, Brazil and Russia.

This comprehensive market analysis presents an overview of the global markets for biotechnology separation systems, and forecasts trends and sales in these markets through 2018. It also examines the separation process for a variety of biomolecules, including proteins, RNA, and DNA. This information will allow the reader to evaluate and quantify the current market size for specific separation systems within the growing biomedical and pharmaceutical technology market.

In addition, this report includes analysis of the leading competitors, as well as emerging companies in the current global biomolecule separation market. Profiles of the manufacturers are analyzed and their specific product strategies are outlined. This report notes companies that are poised to introduce new products during the forecast period and discusses how these products may change the face of the competitive environment. This competitive environment is examined with a special focus on the ways in which developing products and technologies are influencing the current standard of patient care.

This comprehensive technical market research report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants, and anyone interested in the biomolecule separation market, its products, industry participants, and its future.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... the University of Toronto and the University of British Columbia suggested that laws requiring ... injuries. The article explains that part of the reason for the controversial conclusion is ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... ... 2015 , ... A simply groundbreaking television series, "Voices in America", which is ... an array of issues that are presently affecting Americans. Dedicated to providing the world ... is changing the subjects consumers focus on, one episode at a time. , ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 ... of the "Global Brain Monitoring Devices ... --> ) has announced ... Monitoring Devices Market 2015-2019" report to ... Markets ( ) has announced the ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)...  Linden Care, LLC, a retail specialty pharmacy focused ... suffering from chronic pain, said today that it is ... (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy ... --> --> The company said that ... --> --> In ...
Breaking Medicine Technology: